...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> RedHill Biopharma Accelerates RHB-104 Phase III Study in Crohn’s Disease with Top-Line Results Expected Mid-2018
10/02/17
> Vetter Lays the Foundation for a State-of-the-Art Administration Building
09/28/17
> Swiss Biotech Association Strengthens Its Board of Directors and Appoints Michael Altorfer As Its New CEO
09/27/17
> rfxcel Drives EU Expansion with Industry Experts
09/27/17
> OncoQR ML's Vaccine Platform Closes the Final Gap in the Immunological Attack Against Cancer
09/21/17
> SGI-DNA and BioCat Announce Distribution Partnership for Vmax™ Express Protein Expression Platform
09/20/17
> Molecular Devices and Cytena Partner to Launch the CloneSelect Single-Cell Printer
09/19/17
> Aplagon Partners with Cadila Pharmaceuticals to Develop and Commercialize APAC First-in-Class Antithrombotics for the Prevention of Blood Vessel Occlusions Related to Vascular Interventions
09/19/17
> VarmX Announces Publication in Nature Communications of Groundbreaking Snake Venom Inspired Approach to Restore Blood Clotting in Patients Using Anticoagulants
09/18/17
> New In-situ Hydrolysis SPE Plates from Biotage
09/18/17
> Shuwen Biotech Receives CE Mark for EGFR Mutation PCR Kit for Lung Cancer
09/18/17
> Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel Fusion Protein Therapy for Chronic Pain
09/14/17
> Der Sartorius Campus wächst: Einweihung des neuen Produktionsgebäudes für Laborinstrumente
09/13/17
> RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.
09/13/17
> European Patent Office Decides in Synthon's Favor in Glatiramer Patent Case
09/13/17
> Invicro Acquires Imanova to Expand Global Imaging Capabilities
09/12/17
> Successful Industrial GMP Manufacturing of RIBOXXIM, a Novel and Highly Potent Toll-like 3 Ligand for Immunotherapy of Cancer
09/12/17
> New Analysis from German Study Group Prospective Trial Shows Minimal Distant Recurrence in Patients with Clinically High-Risk Breast Cancer and Low Oncotype DX Breast Recurrence Score® Results Following Five Years of Hormone Therapy Alone
09/11/17
> Robust Performance of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients Highlighted at ESMO 2017
09/08/17
> Congenica’s Sapientia™ Selected by Coimbra Paediatric Hospital for Portugal’s In2Genome Genetic Disease Diagnosis Project
09/06/17
> AMAL Therapeutics Raises EUR 8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round
09/05/17
> Asian Study of Over 15,000 Mammograms Underlines the Potential Value of Sigmascreening’s Sensitive Sigma™ Paddle Solution for Pressure Guided Mammography
09/01/17
> Orchard Therapeutics Announces That OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency
08/22/17
> Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse
08/21/17
> RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules
08/17/17
> MIMETAS Develops High-Throughput Gut-on-a-chip Technology in Collaboration with Pharmaceutical Company
08/16/17
> RedHill Biopharma Provides 2017 Semi-Annual Business Update
08/10/17
> Orchard Therapeutics Appoints Mark Rothera as CEO
08/10/17
> RedHill Biopharma Announces Unanimous Positive DSMB Recommendation for Continuation of the Phase III Study with RHB-104 for Crohn's Disease
07/31/17
> BioScience Managers Appoints Elizabeth Klein as Investment Consultant in the UK to Support BioScience Managers' and Downing's Life Sciences Investments
07/31/17
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 2 of 51